Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Equity Average (2018 - 2025)

Inspire Medical Systems' Equity Average history spans 8 years, with the latest figure at $723.8 million for Q4 2025.

  • For Q4 2025, Equity Average rose 4.43% year-over-year to $723.8 million; the TTM value through Dec 2025 reached $723.8 million, up 4.43%, while the annual FY2025 figure was $735.4 million, 16.53% up from the prior year.
  • Equity Average for Q4 2025 was $723.8 million at Inspire Medical Systems, up from $672.1 million in the prior quarter.
  • Across five years, Equity Average topped out at $723.8 million in Q4 2025 and bottomed at $220.1 million in Q3 2021.
  • The 5-year median for Equity Average is $526.9 million (2023), against an average of $478.0 million.
  • The largest annual shift saw Equity Average dropped 4.8% in 2021 before it skyrocketed 128.74% in 2023.
  • A 5-year view of Equity Average shows it stood at $224.7 million in 2021, then skyrocketed by 115.03% to $483.1 million in 2022, then grew by 15.57% to $558.3 million in 2023, then grew by 24.14% to $693.1 million in 2024, then rose by 4.43% to $723.8 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Equity Average are $723.8 million (Q4 2025), $672.1 million (Q3 2025), and $656.8 million (Q2 2025).